KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Prepaid Assets (2016 - 2025)

Sarepta Therapeutics (SRPT) has 14 years of Prepaid Assets data on record, last reported at $192.3 million in Q3 2025.

  • For Q3 2025, Prepaid Assets changed N/A year-over-year to $192.3 million; the TTM value through Sep 2025 reached $192.3 million, changed N/A, while the annual FY2024 figure was $3.7 million, 95.28% down from the prior year.
  • Prepaid Assets reached $192.3 million in Q3 2025 per SRPT's latest filing, up from $4.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $192.3 million in Q3 2025 and bottomed at $1.0 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $67.3 million, with a median of $5.3 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: crashed 98.91% in 2024, then skyrocketed 5303.59% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $5.3 million in 2021, then skyrocketed by 2737.77% to $149.9 million in 2022, then tumbled by 48.15% to $77.7 million in 2023, then plummeted by 95.28% to $3.7 million in 2024, then skyrocketed by 5143.97% to $192.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $192.3 million in Q3 2025, $4.1 million in Q2 2025, and $105.5 million in Q1 2025.